Insulin Resistance: From Mechanisms to Therapeutic Strategies

被引：296

作者：

Lee, Shin-Hae ^{[1
]}

Park, Shi-Young ^{[1
]}

Choi, Cheol Soo ^{[1
,2
,3
]}

机构：

[1] Gachon Univ, Korea Mouse Metab Phenotyping Ctr KMMPC, Lee Gil Ya Canc & Diabet Inst, Incheon, South Korea

[2] Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea

[3] Gachon Univ, Div Mol Med, Coll Med, 21 Namdong Daero 774beon Gil, Incheon 21565, South Korea

来源：

DIABETES & METABOLISM JOURNAL | 2022年 / 46卷 / 01期

基金：

新加坡国家研究基金会;

关键词：

Diabetes mellitus; type; 2; Insulin resistance; Metabolic syndrome; Therapeutics; PROTEIN-KINASE-C; INDUCED HEPATIC STEATOSIS; ELEMENT-BINDING PROTEIN; NECROSIS-FACTOR-ALPHA; GLUCOSE-INDUCED DESENSITIZATION; HEXOSAMINE SYNTHESIS PATHWAY; MUSCLE GLYCOGEN-SYNTHESIS; ACTIVATED RECEPTOR-GAMMA; FATTY-ACID OXIDATION; DIET-INDUCED OBESITY;

D O I：

10.4093/dmj.2021.0280

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Insulin resistance is the pivotal pathogenic component of many metabolic diseases, including type 2 diabetes mellitus, and is defined as a state of reduced responsiveness of insulin-targeting tissues to physiological levels of insulin. Although the underlying mechanism of insulin resistance is not fully understood, several credible theories have been proposed. In this review, we summarize the functions of insulin in glucose metabolism in typical metabolic tissues and describe the mechanisms proposed to underlie insulin resistance, that is, ectopic lipid accumulation in liver and skeletal muscle, endoplasmic reticulum stress, and inflammation. In addition, we suggest potential therapeutic strategies for addressing insulin resistance.

引用

页码：15 / 37

页数：23

共 50 条

[21] ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies
Poei, Darin
Ali, Sana
Ye, Shirley
Hsu, Robert
CANCER DRUG RESISTANCE, 2024, 7
[22] Mechanisms of drug resistance in colon cancer and its therapeutic strategies
Tao Hu
Zhen Li
Chun-Ying Gao
Chi Hin Cho
World Journal of Gastroenterology, 2016, 22 (30) : 6876 - 6889
[23] Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
Normanno, N
Di Maio, M
De Maio, E
De Luca, A
de Matteis, A
Giordano, A
Perrone, F
ENDOCRINE-RELATED CANCER, 2005, 12 (04) : 721 - 747
[24] BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies
Zhong, Jingqin
Yan, Wangjun
Wang, Chunmeng
Liu, Wanlin
Lin, Xinyi
Zou, Zijian
Sun, Wei
Chen, Yong
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (11) : 1503 - 1521
[25] Resistance mechanisms and therapeutic strategies to overcome the resistance in driver oncogene positive NSCLC
Katayama, Ryohei
Fujita, Naoya
CANCER SCIENCE, 2018, 109 : 817 - 817
[26] Molecular mechanisms of TKI and ICI resistance and novel therapeutic strategies to overcome the resistance
Fujita, Naoya
Ebi, Hiromichi
CANCER SCIENCE, 2021, 112 : 132 - 132
[27] Polyclonal resistance to kinase inhibition in GIST: Mechanisms and therapeutic strategies
Fletcher, J.
Rege, T.
Liang, C.
Raut, C.
Foley, K.
Flynn, D.
Corless, C.
Heinrich, M.
Demetri, G.
Wang, Y.
EJC SUPPLEMENTS, 2010, 8 (07): : 83 - 83
[28] Hepatoblastoma: From Molecular Mechanisms to Therapeutic Strategies
Fan, Ling
Na, Jintong
Shi, Tieliu
Liao, Yuan
CURRENT ONCOLOGY, 2025, 32 (03)
[29] FAK in Cancer: From Mechanisms to Therapeutic Strategies
Chuang, Hsiang-Hao
Zhen, Yen-Yi
Tsai, Yu-Chen
Chuang, Cheng-Hao
Hsiao, Michael
Huang, Ming-Shyan
Yang, Chih-Jen
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[30] Regulated Cell Death in Lenvatinib Resistance of Hepatocellular Carcinoma: from Molecular Mechanisms to Therapeutic Strategies
Chen, Ronggao
Hu, Xin
Huang, Yingchen
Jiang, Yao
Chen, Guanrong
Shan, Qiaonan
Xu, Xiao
Zheng, Shusen
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2025, 21 (05):

← 1 2 3 4 5 →